Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 1511 Official Publication of Indian Association of Medical Microbiologists 
 ~   Next article
 ~   Previous article
 ~   Table of Contents

 ~   Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~Related articles
 ~   Citation Manager
 ~   Access Statistics
 ~   Reader Comments
 ~   Email Alert *
 ~   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed19422    
    Printed629    
    Emailed46    
    PDF Downloaded1142    
    Comments [Add]    
    Cited by others 4    

Recommend this journal

 

 REVIEW ARTICLE
Year : 2004  |  Volume : 22  |  Issue : 4  |  Page : 204-211

Superantigens - Concepts, clinical disease and therapy


Department of Microbiology, Sri Ramachandra Medical College and Research Institute, Porur, Chennai - 600 116, India

Correspondence Address:
P Srikanth
Department of Microbiology, Sri Ramachandra Medical College and Research Institute, Porur, Chennai - 600 116
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 17642740

Rights and PermissionsRights and Permissions

The term superantigen was introduced in microbiology and immunology only a decade ago. The unique feature of superantigen is that it bypasses the antigen processing mechanism and specifically binds to TCR v segment and forms a trimolecular complex along with major histocompatibility complex class II. Since its discovery, several studies have been carried out to unravel the properties of superantigens. They are implicated in the pathogenesis of diseases of bacterial, viral and fungal origin. They are also known to play a role in autoimmune diseases. Therapy for these superantigens is being worked upon. Studies have shown that intravenous gamma globulin containing specific antibodies to these superantigens inhibits the activation of T-Cells and also the cytokine production by them resulting in dramatic recovery from superantigen mediated diseases. The use of superantigen in the therapy of cancer is being explored.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04